| Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD N Gupta, JB Wish Am J Kidney Dis, 2017 | 423 | 2017 |
| Perceptions of home dialysis training and experience among US nephrology fellows N Gupta, EB Taber-Hight, BW Miller American Journal of Kidney Diseases 77 (5), 713-718. e1, 2021 | 25 | 2021 |
| Maintaining blood glucose levels in range (70–150 mg/dL) is difficult in COVID-19 compared to non-COVID-19 ICU patients—a retrospective analysis R Kapoor, LR Timsina, N Gupta, H Kaur, AJ Vidger, AM Pollander, ... Journal of Clinical Medicine 9 (11), 3635, 2020 | 18 | 2020 |
| Do current quality measures truly reflect the quality of dialysis? N Gupta, JB Wish Seminars in Dialysis 31 (4), 406-414, 2018 | 15 | 2018 |
| Erythropoietin mimetic peptides and erythropoietin fusion proteins for treating anemia of chronic kidney disease N Gupta, JB Wish Current Opinion in Nephrology and Hypertension 27 (5), 345-350, 2018 | 9 | 2018 |
| Variability of Blazars PJ Wiita, HR Miller, N Gupta, SK Chakrabarti, E Valtaoja, M Valtonen Cambridge University Press, Cambridge, 1992 | 9 | 1992 |
| Accretion disk models for microvariability PJ Wiita, HR Miller, N Gupta, SK Chakrabarti Variability of Blazars, 311, 1992 | 7 | 1992 |
| Is It Time for Precision Dialysis? N Gupta, BJ Wish Clinical Journal of the American Society of Nephrology, 2020 | 6 | 2020 |
| Awareness about contraceptive practices among youths in Delhi R Kapoor, J Kishore, N Gupta Health Popul Perspect Issues 31 (1), 52-62, 2008 | 6 | 2008 |
| Erythropoietin and its cardiovascular effects N Gupta, JB Wish Cardio-Nephrology: Confluence of the Heart and Kidney in Clinical Practice …, 2017 | 4 | 2017 |
| Are dialysis facility quality incentive program scores associated with patient survival? N Gupta, JB Wish American Journal of Kidney Diseases 75 (2), 155-157, 2020 | 2 | 2020 |
| Two-Year Safety and Tolerability of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease, Including Patients Switched From Imiglucerase: Phase III Trial HGT-GCB-039 and … A Mehta, HB Turkia, DE Gonzalez, M Kabra, EA Lukina, P Giraldo, ... Blood 118 (21), 3214, 2011 | 2 | 2011 |
| Impact of geographical Cohorting in the ICU: an academic tertiary care center experience R Kapoor, N Gupta, SD Roberts, C Naum, AJ Perkins, BA Khan Critical Care Explorations 2 (10), e0212, 2020 | 1 | 2020 |
| BONE MINERAL DENSITY IN ADULTS WITH TYPE 1 GAUCHER DISEASE RECEIVING VELAGLUCERASE ALFA 60 U/KG EVERY OTHER WEEK: 2-YEAR RESULTS D Elstein, H Ben Turkia, DE Gonzalez, M Kabra, EA Lukina, P Giraldo, ... Journal of Inherited Metabolic Disease 35, S150-S150, 2012 | 1 | 2012 |
| ACHIEVEMENT OF THERAPEUTIC GOALS IN PATIENTS WITH TYPE 1 GAUCHER DISEASE (GD1) ON VELAGLUCERASE ALFA OR IMIGLUCERASE: PHASE III TRIAL HGT-GCB-039 AND EXTENSION H Ben Turkia, DE Gonzalez, A Zimran, M Kabra, EA Lukina, P Giraldo, ... Journal of Inherited Metabolic Disease 34, S224-S224, 2011 | 1 | 2011 |
| Development of an objective tool to assess dietary compliance in Indian children with GSD and evaluate its reliability A Agarwala, A Gupta, M Kabra, N Gupta Molecular Genetics and Metabolism 136, S12, 2022 | | 2022 |
| Chapter 15: Setting Up, Building, and Sustaining a Home Dialysis Program N Gupta, BW Miller Handbook of Home Hemodialysis 1, 2021 | | 2021 |
| Time to revisit the paradigm for coronary vascular disease in patients with ESKD N Gupta Nephroogy News and Issues, 2020 | | 2020 |
| Clinical and economic disparities between CKD and ESKD care N Gupta Nephrology News and Issues, 2019 | | 2019 |
| Effect of cholecalciferol supplementation on FGF-23 levels in children with chronic kidney disease (CKD) having vitamin D insufficiency A Sheriff, P Hari, RW Thergaonkar, D Bhatia, S Hari, N Gupta, A Sinha, ... PEDIATRIC NEPHROLOGY 29 (12), 2426-2427, 2014 | | 2014 |
Rajat KapoorAssistant professor of Internal MedicineVerified email at iu.edu
